Emily Baker, Ph.D.

Translational oncology researcher passionate about improving cancer patients’ lives. Post-doc at #VUMC in the Rathmell labs. PhD from #UTSW @brekkenlab

[Emily Baker, Ph.D. @enarner]

Excited to share our preprint where we identified impaired mitochondrial metabolism as a driver of epithelial plasticity and primary tumor escape in metastasis. This was a big collaboration with lots of people from VUMC as well as the NCI!

[Jeff Rathmell @JeffRathmell]

Happy to share @enarner preprint on mitochondrial metabolism and kidney cancer metastasis--This ongoing project started with @KimrynRathmell using patient data to show inhibition of oxphos promotes EMT and primary tumor escape. Great work Emily!
https://t.co/TYz2vrwOIL

[Emily Baker, Ph.D. @enarner]

If you’ve made it this far in my tweet, come check out my poster tomorrow between 2-5pm! I’ll be presenting my post-doc work about a metabolic switch we identified that controls tumor cell metabolism and metastasis in kidney cancer. Come see me in Section 12, board 24!

[Emily Baker, Ph.D. @enarner]

So excited to be at #AACR25 in Chicago and receive a scholar in training award from the Kidney Cancer Association (@kidneycan) and the Chris CJ Johnson foundation (@renalmedullary). I’m learning so much. If you see me around, please say hi! #SITAKIDNEY #DayintheLife @kaydaustin

[Emily Baker, Ph.D. @enarner]

Finished off the night at the scholar in training reception, where I networked with so many other amazing early-career investigators as well as @kidneycan @KidneyCancer and @kaydaustin!

[Bill Dahut, MD @billdahutmd]

We are excited to honor the incredible physician-scientist ⁦⁦@KimrynRathmell⁩ with ⁦@AmericanCancer⁩ most important award. Her passion to combine science and care to improve patient outcomes with #kidneycancer is an inspiration to us all https://t.co/m0Bm6sNYM9

[UTSW Simmons Cancer Center @utswcancer]

#UTSW scientists have discovered a mechanism that promotes metastasis in pancreatic, breast, and potentially other cancers along with a new druggable therapeutic target to block it. @brekkenlab @scisignal https://t.co/7lIFFJOam5

[Science Signaling @scisignal]

Studying the mechanisms of #EpithelialToMesenchymal transition, researchers investigated the kinase AKT and identified a pathway centered on TBK1 required for EMT and metastatic spread in pancreatic cancer in mice. @UTSWCancerBio @brekkenlab @enarner https://t.co/DMYkbcaD6N

[Emily Baker, Ph.D. @enarner]

@aguilera_md @brekkenlab @UiB Thanks Todd!!

[Emily Baker, Ph.D. @enarner]

@brekkenlab You need to convince them to get a twitter!!

[Emily Baker, Ph.D. @enarner]

It’s finally out!! It’s been 3 years since I graduated with my PhD from UTSW, but my last first-author paper from grad school and the culmination of my thesis work has finally been published in @scisignal!! https://t.co/vzz1g1ZQQ2

[Emily Baker, Ph.D. @enarner]

@JMarkedCooper @brekkenlab Thanks @JMarkedCooper! There’s lots of ways this pathway can be targeted for the treatment of metastasis. I hope they can make a difference!

[Emily Baker, Ph.D. @enarner]

Thanks to Rolf and everyone in the @brekkenlab for not giving up and pushing this out the door! Especially Dina and Jill! I’m extremely grateful to the whole crew and glad to see this out there!

[Emily Baker, Ph.D. @enarner]

We found that TBK1 activates the specific AKT isoform, AKT3, to drive stability of EMT transcription factors for subsequent EMT and metastasis!

[Jeff Rathmell @JeffRathmell]

Great to see this story out @jclinicalinvest by @Newcomblab
Sex differences and immunometabolism

https://t.co/kCjlftGdjV

[Oded Rechavi @OdedRechavi]

For a PhD student, choosing a good lab is 10 times more important than choosing a particular topic to study

[Emily Baker, Ph.D. @enarner]

@may_alley @uvaurology @DoctorKvoss just started her lab at UVA! You guys should be friends!!